Given the reported dysregulation of IRF1 in myeloid malignancies (39, 65), which may parallel its role in murine HSC function, we explored the potential of using IRF1-based stratification to identify distinct subgroups in human AML. This evidence concerns the gene IRF1 and acute myeloid leukemia.